Clinical Trial Update: Effect of an Inhaled Glucocorticosteroid (ICS) on Endothelial Dysfunction in Cigarette Smokers [NA]

View source ↗

Summary

A completed trial evaluated whether an inhaled glucocorticosteroid improves endothelial dysfunction in cigarette smokers, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Inhaled glucocorticosteroid (corticosteroid)

Snippet

Sponsor: University of Miami | Conditions: Tobacco Abuse Smoke | NA | Status: COMPLETED | Results posted: 2014-12-05